The role of miRNAs in cardiovascular disease risk factors
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 254, 271-281
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglyceridesNature, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- The miR-15/107 Group of MicroRNA Genes: Evolutionary Biology, Cellular Functions, and Roles in Human DiseasesJournal of Molecular Biology, 2010
- A translational study of circulating cell-free microRNA-1 in acute myocardial infarctionClinical Science, 2010
- miR-145 and miR-143 regulate smooth muscle cell fate and plasticityNature, 2009
- Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat dietBiochemical and Biophysical Research Communications, 2008
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and AngiogenesisDevelopmental Cell, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005